MLTX
Price
$15.37
Change
+$5.99 (+63.86%)
Updated
Feb 3, 04:59 PM (EDT)
Capitalization
1.12B
23 days until earnings call
Intraday BUY SELL Signals
RARE
Price
$24.80
Change
-$6.86 (-21.67%)
Updated
Feb 3, 04:59 PM (EDT)
Capitalization
2.39B
9 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

MLTX vs RARE

Header iconMLTX vs RARE Comparison
Open Charts MLTX vs RAREBanner chart's image
MoonLake Immunotherapeutics
Price$15.37
Change+$5.99 (+63.86%)
Volume$13.98K
Capitalization1.12B
Ultragenyx Pharmaceutical
Price$24.80
Change-$6.86 (-21.67%)
Volume$61.84K
Capitalization2.39B
MLTX vs RARE Comparison Chart in %
MLTX
Daily Signal:
Gain/Loss:
RARE
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
MLTX vs. RARE commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLTX is a Hold and RARE is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 04, 2026
Stock price -- (MLTX: $15.79 vs. RARE: $24.76)
Brand notoriety: MLTX and RARE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MLTX: 61% vs. RARE: 117%
Market capitalization -- MLTX: $1.12B vs. RARE: $2.39B
MLTX [@Biotechnology] is valued at $1.12B. RARE’s [@Biotechnology] market capitalization is $2.39B. The market cap for tickers in the [@Biotechnology] industry ranges from $119.76B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MLTX’s FA Score shows that 1 FA rating(s) are green whileRARE’s FA Score has 0 green FA rating(s).

  • MLTX’s FA Score: 1 green, 4 red.
  • RARE’s FA Score: 0 green, 5 red.
According to our system of comparison, MLTX is a better buy in the long-term than RARE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MLTX’s TA Score shows that 4 TA indicator(s) are bullish while RARE’s TA Score has 5 bullish TA indicator(s).

  • MLTX’s TA Score: 4 bullish, 6 bearish.
  • RARE’s TA Score: 5 bullish, 6 bearish.
According to our system of comparison, RARE is a better buy in the short-term than MLTX.

Price Growth

MLTX (@Biotechnology) experienced а -0.75% price change this week, while RARE (@Biotechnology) price change was +1.85% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.27%. For the same industry, the average monthly price growth was +3.31%, and the average quarterly price growth was +36.66%.

Reported Earning Dates

MLTX is expected to report earnings on Feb 26, 2026.

RARE is expected to report earnings on Feb 12, 2026.

Industries' Descriptions

@Biotechnology (-4.27% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RARE($2.39B) has a higher market cap than MLTX($1.12B). MLTX YTD gains are higher at: 19.803 vs. RARE (7.652). MLTX has higher annual earnings (EBITDA): -227.94M vs. RARE (-483.37M). RARE has more cash in the bank: 425M vs. MLTX (380M). RARE has less debt than MLTX: RARE (33.8M) vs MLTX (75.7M). RARE has higher revenues than MLTX: RARE (631M) vs MLTX (0).
MLTXRAREMLTX / RARE
Capitalization1.12B2.39B47%
EBITDA-227.94M-483.37M47%
Gain YTD19.8037.652259%
P/E RatioN/AN/A-
Revenue0631M-
Total Cash380M425M89%
Total Debt75.7M33.8M224%
FUNDAMENTALS RATINGS
RARE: Fundamental Ratings
RARE
OUTLOOK RATING
1..100
10
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
6

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MLTXRARE
RSI
ODDS (%)
Bearish Trend 2 days ago
61%
Bullish Trend 2 days ago
70%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
71%
Momentum
ODDS (%)
Bearish Trend 2 days ago
59%
Bullish Trend 2 days ago
76%
MACD
ODDS (%)
Bearish Trend 2 days ago
58%
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
61%
Bullish Trend 2 days ago
74%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
71%
Advances
ODDS (%)
Bullish Trend 8 days ago
83%
Bullish Trend 8 days ago
77%
Declines
ODDS (%)
Bearish Trend 5 days ago
74%
Bearish Trend 5 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
72%
Bullish Trend 5 days ago
76%
Aroon
ODDS (%)
Bearish Trend 2 days ago
60%
Bearish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
MLTX
Daily Signal:
Gain/Loss:
RARE
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PRSVX54.620.50
+0.92%
T. Rowe Price Small-Cap Value
KTCCX12.910.05
+0.39%
DWS Science and Technology C
FDERX21.090.07
+0.33%
Federated Hermes Strategic Div Gr R
WLTTX12.560.01
+0.08%
Wilshire International Equity Instl
RSRFX10.78-0.07
-0.65%
Reaves Infrastructure Fund Class Inst

MLTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLTX has been closely correlated with KALA. These tickers have moved in lockstep 84% of the time. This A.I.-generated data suggests there is a high statistical probability that if MLTX jumps, then KALA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLTX
1D Price
Change %
MLTX100%
+0.77%
KALA - MLTX
84%
Closely correlated
-0.47%
NEVPF - MLTX
70%
Closely correlated
N/A
IOBT - MLTX
60%
Loosely correlated
-4.17%
XNCR - MLTX
50%
Loosely correlated
+0.17%
NUVL - MLTX
48%
Loosely correlated
+2.00%
More

RARE and

Correlation & Price change

A.I.dvisor indicates that over the last year, RARE has been closely correlated with MREO. These tickers have moved in lockstep 84% of the time. This A.I.-generated data suggests there is a high statistical probability that if RARE jumps, then MREO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RARE
1D Price
Change %
RARE100%
+2.87%
MREO - RARE
84%
Closely correlated
-1.70%
VCYT - RARE
46%
Loosely correlated
+0.21%
INO - RARE
45%
Loosely correlated
+4.29%
MLTX - RARE
37%
Loosely correlated
+0.77%
AMRN - RARE
36%
Loosely correlated
+0.50%
More